New England Journal
-
{
- All
- News
- Videos
-
Understanding Yo-Yo Dieting And Its Health Risks
From metabolic disturbances to heart health risks, understanding the disadvantages of yo-yo dieting is crucial for long-term well-being.
-
Covid Linked To Lower IQ, Poor Memory And Brain Ageing: Study
A new study published in the New England Journal of Medicine suggests that being infected with SARS-CoV-2 - the virus that causes COVID-19 - profoundly impacts brain health in many ways.
-
Man's Skin Turns Red And Blistery After Eating Undercooked Shiitake Mushrooms
The man experienced the painful rash just two days after consuming undercooked shiitake mushrooms.
-
Magic Mushrooms' Psilocybin Treats Severe Depression, Says Study
This study showed that participants' depressive symptoms were relieved by a single 25-mg dose of psilocybin.
-
Fourth Covid Shot Provides Little Benefit Against Omicron: Study
A fourth dose of existing mRNA Covid-19 vaccines may have only "marginal benefits" for younger, healthy adults, according to a new Israeli study published Wednesday in the New England Journal of Medicine.
-
Researchers Urge Delaying Second Pfizer Jab As First "Highly Effective"
The second dose of Pfizer Inc's COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based researchers said in a letter published in the New England Journal of Medicine.
-
"Triumph": Pfizer Vaccine Results Published In Peer-Reviewed Journal
The full results of a clinical trial for the Pfizer-BioNTech Covid-19 vaccine were published in the New England Journal of Medicine on Thursday, a major milestone that came as a committee of the US Food and Drug Administration met to discuss its approval.
-
Moderna Vaccine Protects 16 Monkeys, Faces Bigger Test On 30,000 Humans
Moderna Inc.'s vaccine candidate against Covid-19 protected against the virus in a trial that inoculated 16 monkeys, an encouraging step on the path to a defense for humans against the pandemic.
-
Moderna's COVID-19 Vaccine Worked Well In Monkeys: Study
US biotech firm Moderna's COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses and lungs of monkeys, a study in the New England Journal of Medicine said Tuesday.
-
Covid Antibodies Fade Rapidly, May Not Offer Lasting Immunity: Report
Recovering from Covid-19 may not offer much lasting protection from future infections for those with only mild cases, according to a report that suggests caution regarding so-called herd immunity as well as the durability of vaccines.
-
Understanding Yo-Yo Dieting And Its Health Risks
From metabolic disturbances to heart health risks, understanding the disadvantages of yo-yo dieting is crucial for long-term well-being.
-
Covid Linked To Lower IQ, Poor Memory And Brain Ageing: Study
A new study published in the New England Journal of Medicine suggests that being infected with SARS-CoV-2 - the virus that causes COVID-19 - profoundly impacts brain health in many ways.
-
Man's Skin Turns Red And Blistery After Eating Undercooked Shiitake Mushrooms
The man experienced the painful rash just two days after consuming undercooked shiitake mushrooms.
-
Magic Mushrooms' Psilocybin Treats Severe Depression, Says Study
This study showed that participants' depressive symptoms were relieved by a single 25-mg dose of psilocybin.
-
Fourth Covid Shot Provides Little Benefit Against Omicron: Study
A fourth dose of existing mRNA Covid-19 vaccines may have only "marginal benefits" for younger, healthy adults, according to a new Israeli study published Wednesday in the New England Journal of Medicine.
-
Researchers Urge Delaying Second Pfizer Jab As First "Highly Effective"
The second dose of Pfizer Inc's COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based researchers said in a letter published in the New England Journal of Medicine.
-
"Triumph": Pfizer Vaccine Results Published In Peer-Reviewed Journal
The full results of a clinical trial for the Pfizer-BioNTech Covid-19 vaccine were published in the New England Journal of Medicine on Thursday, a major milestone that came as a committee of the US Food and Drug Administration met to discuss its approval.
-
Moderna Vaccine Protects 16 Monkeys, Faces Bigger Test On 30,000 Humans
Moderna Inc.'s vaccine candidate against Covid-19 protected against the virus in a trial that inoculated 16 monkeys, an encouraging step on the path to a defense for humans against the pandemic.
-
Moderna's COVID-19 Vaccine Worked Well In Monkeys: Study
US biotech firm Moderna's COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses and lungs of monkeys, a study in the New England Journal of Medicine said Tuesday.
-
Covid Antibodies Fade Rapidly, May Not Offer Lasting Immunity: Report
Recovering from Covid-19 may not offer much lasting protection from future infections for those with only mild cases, according to a report that suggests caution regarding so-called herd immunity as well as the durability of vaccines.
